Diseases, Conditions, Syndromes

Drug shows promise in 1st largely minority COVID-19 study

A drug company said Friday that a medicine it sells to tamp down inflammation has helped prevent the need for breathing machines in hospitalized COVID-19 patients in the first large study that primarily enrolled Hispanics ...

Diseases, Conditions, Syndromes

Study provides more data on blood thinner efficacy for COVID-19

Early in the COVID-19 pandemic, Mount Sinai researchers were among the first to show that anticoagulation therapy was associated with improved survival among hospitalized COVID-19 patients. But many questions remained—about ...

Diseases, Conditions, Syndromes

Study finds hydroxychloroquine reduces in-hospital COVID-19 mortality

An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic. The research, conducted on 3,451 patients treated in 33 hospitals throughout the Italian territory ...

page 1 from 25